You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Worldwide Clinical Trials, Inc., (Worldwide) the industrys leading global, mid-sized, full-service contract research organization (CRO), today announced the appointment of Peter Lammers as Executive Vice President, Global Marketing and Commercial Operations. This move takes place during a period of dynamic growth for the company, as the outlook for its primary target market small to mid-sized pharmaceutical organizations and biotechs remains strong. An experienced life sciences business strategist and marketer with more than 30 years of experience working for pharmaceutical organizations and CROs, Lammers will champion Worldwides promise to improve the CRO experience for small to mid-sized pharmaceutical organizations and biotechs. Lammers has first-hand understanding of the challenges faced by smaller organizations and will use that perspective to drive new and existing customer revenue growth. "I'm delighted to welcome Peter to the Worldwide team as we continue to cultivate an environment where smaller organizations can find the innovation, flexibility and senior team accessibility that is hard to come by in large, commoditized CROs, said Worldwide President and Chief Operating Officer, Peter Benton. "Peters innovative approach to developing transformational business models could not come at a better time as we double down on our vision of becoming the worlds best midsized CRO." Lammers will also spearhead Worldwides brand development - ensuring the customer is prioritized across the companys commercial, scientific and operations teams. Lammers joins Worldwide from Ironshore Pharmaceuticals, Inc., a North Carolina-based pharmaceutical start-up, where he oversaw commercialization launch strategy and brand positioning for a novel therapy in a highly competitive indication. Prior to that, he provided strategic vision and commercial advisory services for global companies like Veeva Systems and IQVIA. Lammers has also held senior leadership roles at Glaxo SmithKline PLC. Our scientific and medical grounding, when paired with a culture laser-focused on quality and customer service, presents a tremendous opportunity for Worldwide to redefine the CRO experience for small and midsized pharma and biotech sponsors, said Lammers. I am excited to apply my 30+ years of life science experience as a customer and as a service provider to improve every touchpoint with sponsors and deliver the best customer experience. Lammers holds a BS in business from Westminster College in Fulton, Missouri, and has completed leadership programs at the University of North Carolina, Duke University and the University of Pennsylvanias Wharton Business School. Interested in improving the CRO experience? Worldwide is hiring. About Worldwide Clinical Trials Worldwide Clinical Trials employs more than 2,000+ professionals around the world, with offices in North and South America, Eastern and Western Europe, Russia, and Asia. Founded by physicians committed to advancing medical science, Worldwide is out to change how the world experiences CROs in the best possible way. From early phase and bioanalytical sciences through late phase, post-approval and real-world evidence, we provide world-class, full-service drug development services. With infrastructure and talent spanning 60 countries, we execute predictable, successful studies with operational excellence across a range of therapeutic areas, including central nervous system, cardiovascular, metabolic, general medicine, oncology and rare diseases. We never compromise on science or safety. Were never satisfied with the status quo. Were the Cure for the Common CRO. For more information, visit www.worldwide.com..

Answer: Worldwide Clinical Trials Appoints Head of Global Marketing and Commercial Operations Peter Lammers to Help Lead CRO Through Era of Targeted Growth